Literature DB >> 19579698

Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.

Sara Botto1, Massimiliano Bergallo, Francesca Sidoti, Maria Elena Terlizzi, Sara Astegiano, Renata Ponti, Cristina Costa, Rossana Cavallo.   

Abstract

The molecular epidemiology and tissue distribution of Human Parvovirus 4 (PARV4) and its variant PARV5 (Parvoviridae family) are poorly known. The aim of this study was to investigate the epidemiological role and prevalence of PARV4/5 by a nested-PCR on different clinical specimens, including blood samples from healthy donors, healthy and pathological skin samples, and bronchoalveolar lavages (BAL). Among blood specimens, 2/53 were positive; 3/37 and 23/105 of healthy and pathological skin specimens resulted positive, respectively, whereas no BAL was positive. PARV4/5 may be present in different healthy and pathological samples, suggesting the need for further investigating its tissue distribution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579698

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  6 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?

Authors:  Eric Delwart
Journal:  Transfusion       Date:  2012-07       Impact factor: 3.157

3.  No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults.

Authors:  Thomas Tolfvenstam; Oscar Norbeck; Lars Ohrmalm
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

4.  Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).

Authors:  Fabiana Corcioli; Krystyna Zakrzewska; Rosa Fanci; Vincenzo De Giorgi; Massimo Innocenti; Matteo Rotellini; Simonetta Di Lollo; Alberta Azzi
Journal:  Virol J       Date:  2010-10-15       Impact factor: 4.099

5.  High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.

Authors:  Ruth Simmons; Colin Sharp; Stuart Sims; Henrik Kloverpris; Philip Goulder; Peter Simmonds; Paul Bowness; Paul Klenerman
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

6.  Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection.

Authors:  Rui Tong; Liping Shen; Wenjiao Yin; Weimin Zhou; Jian Lu; Meiqin Zheng; Shengli Bi; Yongliang Lou; Wenjie Tan
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.